Home › Critical Illness › NCT06923462
VoiceLove: An App-Based COMMunication Tool Designed to Address DeliriUm and Improve Family ENgagement and PatIent/Family SatisfaCtion in CriticAlly Ill PaTiEnts (COMMUNICATE)
Recruiting
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria Only patients who meet inclusion criteria, have no exclusion criteria, and consent for participation will advance to the Interventional Trial phase (i.e., the randomization phase) of the study. Patients will be eligible for inclusion in the Pre-Randomization Phase of the study (i.e., presented for study consent) if they are: 1. Adult patient ≥18 years old 2. Admitted to medical or coronary ICU 3. Intubated on mechanical ventilation with expected intubation of \> 24 hours Exclusion Criteria Patients will be excluded (i.e., not consented) for any of the following reasons: 1. Inability to obtain informed consent * Attending physician refusal * Patient and/or surrogate refusal * Patient unable to consent and no surrogate available 2. Acute or chronic neurologic deficit precluding CAM-ICU assessments 3. Inability to understand English 4. Current enrollment in a study that does not allow co-enrollment 5. Prisoners 6. Expected death or comfort measures within 24 hours of enrollment or lack of commitment to intervention by family or the medical team (e.g., likely to withdraw life support measures within 24 hours of enrollment). 7. Bilateral Deafness
About the study
VoiceLove is a phone application allowing family and patients to share information in a secure platform. This project will compare the VoiceLove app to usual care to learn about whether VoiceLove improves patient-family communication, family engagement, and ICU delirium.
What is being tested
- Communication Application (other)
Sponsor: Vanderbilt University Medical Center · Participants: 100 · Started: Aug 6, 2025
Contact the study team
- Christina Boncyk, MD, MPH · Phone: 615-936-2857
- Rebecca Abel, MA · Phone: 615-875-3763
Official record on ClinicalTrials.gov — NCT06923462
Locations in the U.S.
| Tennessee | Vanderbilt University Medical Center, Nashville |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.